APO RESEARCH · REPORT
Polycaprolactone
Polycaprolactone (PCL) is a synthetic semicrystalline biodegradable polyester with a melting point of approximately 60 °C and a glass transition temperature of about −60 °C.
Product & engineering
Understand the product.
Polycaprolactone (PCL) is a synthetic semicrystalline biodegradable polyester with a melting point of approximately 60 °C and a glass transition temperature of about −60 °C. It is most commonly used in the production of specialty polyurethanes, imparting excellent resistance to water, oil, solvents, and chlorine. Chemically, it consists of the repeating unit (C₆H₁₀O₂)ₙ, with the systematic IUPAC name poly(hexano-6-lactone) and CAS registry number 24980-41-4. Typical physical properties include a density of 1.145 g/cm³ and thermal conductivity of 0.05 W/(m·K) at 25 °C. PCL undergoes biodegradation through hydrolysis of its ester bonds under physiological conditions and is degradable by microorganisms from the Bacillota and Pseudomonadota phyla. It has received FDA approval for select human applications such as drug delivery devices, sutures, and adhesion barriers.
Polycaprolactone is synthesized primarily by ring-opening polymerization of ε-caprolactone, catalyzed most often by stannous octoate in the presence of low-molecular-weight alcohols as chain-length modifiers. This process enables precise control of molecular weight, yielding products ranging from low-molecular-weight polyols to high-molecular-weight resins. In industrial applications, PCL functions as a specialty polyol for thermoplastic polyurethane elastomers, coatings, adhesives, sealants, and cast elastomers, delivering superior low-temperature flexibility, hydrolytic stability, low melt viscosity, and light stability. In biomedical fields, it serves as a bioabsorbable polymer for long-term implants, controlled-release drug systems, tissue engineering scaffolds, bone repair composites, dental materials, and dermal fillers, with tunable intrinsic viscosity, degradation profiles spanning months to years, and customizable end groups.
Additional uses include resin additives to improve processability and impact resistance, blends with starch for enhanced biodegradability and cost efficiency, polymeric plasticizers for polyvinyl chloride, and filaments for fused deposition modeling 3D printing. Polycaprolactone combines outstanding biocompatibility, complete biodegradability to carbon dioxide and water, and excellent processability through low melt viscosity and good solubility. Its performance can be tailored via molecular weight, copolymer ratios, and end-group chemistry to satisfy GMP-grade and FDA requirements, positioning it as a foundational material for high-performance industrial polyurethanes and advanced biomedical technologies.
Composition, supplied form and processing history determine the usable material. Evaluate the property required by the actual application with the specified test method; a chemistry name alone does not define a finished grade.
What turns activity into demand
Qualified formulation or component output creates material purchases through loading, process yield and the supplied mass basis. Raw material, formulated blend and finished-part revenues describe separate transaction stages.
The commercial boundary
For Polycaprolactone, distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.
Which conditions determine usable polycaprolactone performance?
Polycaprolactone (PCL) is a synthetic semicrystalline biodegradable polyester with a melting point of approximately 60 °C and a glass transition temperature of about −60 °C. Match formulation and impurity limits to the converting process, then verify the property after processing or curing. Compare like-for-like dry or as-supplied quantities; a finished component and its raw material represent different transaction stages.
Selected research
Industry Research
Polycaprolactone Industry Research Report 2026
Market perspective
Polycaprolactone (PCL) is a synthetic semicrystalline biodegradable polyester with a melting point of approximately 60 °C and a glass transition temperature of about −60 °C. It is most commonly used in the production of specialty polyurethanes, imparting excellent resistance to water, oil, solvents, and chlorine. Chemically, it consists of the repeating unit (C₆H₁₀O₂)ₙ, with the systematic IUPAC name poly(hexano-6-lactone) and CAS registry number 24980-41-4. Typical physical properties include a density of 1.145 g/cm³ and thermal conductivity of 0.05 W/(m·K) at 25 °C. PCL undergoes biodegradation through hydrolysis of its ester bonds under physiological conditions and is degradable by microorganisms from the Bacillota and Pseudomonadota phyla. It has received FDA approval for select human applications such as drug delivery devices, sutures, and adhesion barriers.
Polycaprolactone is synthesized primarily by ring-opening polymerization of ε-caprolactone, catalyzed most often by stannous octoate in the presence of low-molecular-weight alcohols as chain-length modifiers. This process enables precise control of molecular weight, yielding products ranging from low-molecular-weight polyols to high-molecular-weight resins. In industrial applications, PCL functions as a specialty polyol for thermoplastic polyurethane elastomers, coatings, adhesives, sealants, and cast elastomers, delivering superior low-temperature flexibility, hydrolytic stability, low melt viscosity, and light stability. In biomedical fields, it serves as a bioabsorbable polymer for long-term implants, controlled-release drug systems, tissue engineering scaffolds, bone repair composites, dental materials, and dermal fillers, with tunable intrinsic viscosity, degradation profiles spanning months to years, and customizable end groups.
Additional uses include resin additives to improve processability and impact resistance, blends with starch for enhanced biodegradability and cost efficiency, polymeric plasticizers for polyvinyl chloride, and filaments for fused deposition modeling 3D printing. Polycaprolactone combines outstanding biocompatibility, complete biodegradability to carbon dioxide and water, and excellent processability through low melt viscosity and good solubility. Its performance can be tailored via molecular weight, copolymer ratios, and end-group chemistry to satisfy GMP-grade and FDA requirements, positioning it as a foundational material for high-performance industrial polyurethanes and advanced biomedical technologies.
Read the full market overview
The global Polycaprolactone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Polycaprolactone is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Polycaprolactone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Polycaprolactone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Polycaprolactone include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Polycaprolactone market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Polycaprolactone.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Polycaprolactone Market by Company
Ingevity
Daicel
BASF
Hunan Juren Chemical
Corbion
Seqens International
Shenzhen Esun Industrial
Polycaprolactone Segment by Type
Double Functional Caprolactone
Tri Functional Caprolactone
High Molar Mass PCL Polymers
Others
Polycaprolactone Segment by Application
Resins & Coatings
Elastomers
Adhesives
Medical Devices
Others
Polycaprolactone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polycaprolactone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polycaprolactone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polycaprolactone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Polycaprolactone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Polycaprolactone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Polycaprolactone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Double Functional Caprolactone
- Tri Functional Caprolactone
- High Molar Mass PCL Polymers
- Others
Applications
- Resins & Coatings
- Elastomers
- Adhesives
- Medical Devices
- Others
Companies covered
- Ingevity
- Daicel
- BASF
- Hunan Juren Chemical
- Corbion
- Seqens International
- Shenzhen Esun Industrial
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Polycaprolactone by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Double Functional Caprolactone
- 2.2.3 Tri Functional Caprolactone
- 2.2.4 High Molar Mass PCL Polymers
- 2.2.5 Others
- 2.3 Polycaprolactone by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Resins & Coatings
- 2.3.3 Elastomers
- 2.3.4 Adhesives
- 2.3.5 Medical Devices
- 2.3.6 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Polycaprolactone Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Polycaprolactone Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Polycaprolactone Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Polycaprolactone Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Polycaprolactone Production by Manufacturers (2021-2026)
- 3.2 Global Polycaprolactone Production Value by Manufacturers (2021-2026)
- 3.3 Global Polycaprolactone Average Price by Manufacturers (2021-2026)
- 3.4 Global Polycaprolactone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Polycaprolactone Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Polycaprolactone Manufacturers, Product Type & Application
- 3.7 Global Polycaprolactone Manufacturers Established Date
- 3.8 Global Polycaprolactone Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ingevity
- 4.1.1 Ingevity Polycaprolactone Company Information
- 4.1.2 Ingevity Polycaprolactone Business Overview
- 4.1.3 Ingevity Polycaprolactone Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Ingevity Product Portfolio
- 4.1.5 Ingevity Recent Developments
- 4.2 Daicel
- 4.2.1 Daicel Polycaprolactone Company Information
- 4.2.2 Daicel Polycaprolactone Business Overview
- 4.2.3 Daicel Polycaprolactone Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Daicel Product Portfolio
- 4.2.5 Daicel Recent Developments
- 4.3 BASF
- 4.3.1 BASF Polycaprolactone Company Information
- 4.3.2 BASF Polycaprolactone Business Overview
- 4.3.3 BASF Polycaprolactone Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 BASF Product Portfolio
- 4.3.5 BASF Recent Developments
- 4.4 Hunan Juren Chemical
- 4.4.1 Hunan Juren Chemical Polycaprolactone Company Information
- 4.4.2 Hunan Juren Chemical Polycaprolactone Business Overview
- 4.4.3 Hunan Juren Chemical Polycaprolactone Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Hunan Juren Chemical Product Portfolio
- 4.4.5 Hunan Juren Chemical Recent Developments
- 4.5 Corbion
- 4.5.1 Corbion Polycaprolactone Company Information
- 4.5.2 Corbion Polycaprolactone Business Overview
- 4.5.3 Corbion Polycaprolactone Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Corbion Product Portfolio
- 4.5.5 Corbion Recent Developments
- 4.6 Seqens International
- 4.6.1 Seqens International Polycaprolactone Company Information
- 4.6.2 Seqens International Polycaprolactone Business Overview
- 4.6.3 Seqens International Polycaprolactone Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Seqens International Product Portfolio
- 4.6.5 Seqens International Recent Developments
- 4.7 Shenzhen Esun Industrial
- 4.7.1 Shenzhen Esun Industrial Polycaprolactone Company Information
- 4.7.2 Shenzhen Esun Industrial Polycaprolactone Business Overview
- 4.7.3 Shenzhen Esun Industrial Polycaprolactone Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Shenzhen Esun Industrial Product Portfolio
- 4.7.5 Shenzhen Esun Industrial Recent Developments
5 Global Polycaprolactone Production by Region
- 5.1 Global Polycaprolactone Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Polycaprolactone Production by Region: 2021-2032
- 5.2.1 Global Polycaprolactone Production by Region: 2021-2026
- 5.2.2 Global Polycaprolactone Production Forecast by Region (2027-2032)
- 5.3 Global Polycaprolactone Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Polycaprolactone Production Value by Region: 2021-2032
- 5.4.1 Global Polycaprolactone Production Value by Region: 2021-2026
- 5.4.2 Global Polycaprolactone Production Value Forecast by Region (2027-2032)
- 5.5 Global Polycaprolactone Market Price Analysis by Region (2021-2026)
- 5.6 Global Polycaprolactone Production and Value, YOY Growth
- 5.6.1 North America Polycaprolactone Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Polycaprolactone Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Polycaprolactone Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Polycaprolactone Production Value Estimates and Forecasts (2021-2032)
6 Global Polycaprolactone Consumption by Region
- 6.1 Global Polycaprolactone Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Polycaprolactone Consumption by Region (2021-2032)
- 6.2.1 Global Polycaprolactone Consumption by Region: 2021-2026
- 6.2.2 Global Polycaprolactone Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Polycaprolactone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Polycaprolactone Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Polycaprolactone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Polycaprolactone Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Polycaprolactone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Polycaprolactone Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Polycaprolactone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Polycaprolactone Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Polycaprolactone Production by Type (2021-2032)
- 7.1.1 Global Polycaprolactone Production by Type (2021-2032) & (t)
- 7.1.2 Global Polycaprolactone Production Market Share by Type (2021-2032)
- 7.2 Global Polycaprolactone Production Value by Type (2021-2032)
- 7.2.1 Global Polycaprolactone Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Polycaprolactone Production Value Market Share by Type (2021-2032)
- 7.3 Global Polycaprolactone Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Polycaprolactone Production by Application (2021-2032)
- 8.1.1 Global Polycaprolactone Production by Application (2021-2032) & (t)
- 8.1.2 Global Polycaprolactone Production Market Share by Application (2021-2032)
- 8.2 Global Polycaprolactone Production Value by Application (2021-2032)
- 8.2.1 Global Polycaprolactone Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Polycaprolactone Production Value Market Share by Application (2021-2032)
- 8.3 Global Polycaprolactone Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Polycaprolactone Value Chain Analysis
- 9.1.1 Polycaprolactone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Polycaprolactone Production Mode & Process
- 9.2 Polycaprolactone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Polycaprolactone Distributors
- 9.2.3 Polycaprolactone Customers
10 Global Polycaprolactone Analyzing Market Dynamics
- 10.1 Polycaprolactone Industry Trends
- 10.2 Polycaprolactone Industry Drivers
- 10.3 Polycaprolactone Industry Opportunities and Challenges
- 10.4 Polycaprolactone Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst